Indivior Pharmaceuticals, Inc. (INDV)
Healthcare
Drug Manufacturers - Specialty & Generic
37.40 $
-6.6%
vs. previous close
Closing price · As of: 3. Aug 2026
Listed US companies must report material events to the Securities and Exchange Commission. This page lists the filings of Indivior Pharmaceuticals, Inc. (INDV) with date, type and a link to the original document.
| Date | Type | Filing | Original |
|---|---|---|---|
| 08/03/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Regulation FD Disclosure; Financial Statements and Exhibits | View report → |
| 08/03/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Results of Operations and Financial Condition; Regulation FD Disclosure; Financial Statements and Exhibits | View report → |
| 08/03/2026 | Current report (8-K) | Indivior Pharmaceuticals, Inc. (INDV): Entry into a Material Definitive Agreement; Regulation FD Disclosure; Financial Statements and Exhibits | View report → |
| 07/10/2026 | Insider sale notice | Form 144 filed with the SEC | View document → |
Showing the 100 most recent filings of the selected type.
Data as of: August 3, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Filings: SEC EDGAR
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.